ITRM

Iterum Therapeutics
ITRM

Latest price

Financial Snapshot

gainify

Market Data

Market Cap
$48.07M
EV
$69.54M
Shares Outstanding
34.58M
Beta
2.88

Wall Street View

Analyst Rating
OUTPERFORM
Analyst Target Price
$5.00
P/E 2025E
-
P/Revenue 2025E
5.15x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Iterum Therapeutics plc

gainify
ITRM

Iterum Therapeutics plc

ITRM

Iterum Therapeutics plc, a clinical-stage pharmaceutical company, engages in developing and commercializing anti-infectives in Ireland, Bermuda, and the United States. It is developing sulopenem, a novel anti-infective compound with oral and intravenous formulations t...

Sector

Healthcare

Industry

Biotechnology

CEO

Fishman, Corey

Employees

9

IPO Date

2018-05-25

Headquarters

Fitzwilliam Court, 1st Floor, Leeson Close, Dublin, Co. Dublin, D02 YW24, Ireland

gainify
mailcontactcontact
powered-by-sp

NEWSLETTER

COMPANY

© Copyright 2025, All Rights Reserved